hange the treatment paradigm for patients with autoimmune and inflammatory diseases.
Mozart is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases. They aim to reset and restore the balance of the immune system by leveraging a novel pathway to develop first-in-class CD8 Treg modulators to delay onset, reduce severity and potentially reverse the course of disease that allow patients to lead normal lives.
Katie Fanning
Mark M. Davis, PhD
K. Christopher Garcia, PhD
Calvin Kuo, MD, PhD
April 2021